Bank Pictet & Cie (Europe)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-742
Closed -$348K 161
2024
Q2
$348K Sell
742
-296
-29% -$139K 0.01% 129
2024
Q1
$434K Sell
1,038
-69
-6% -$28.8K 0.01% 137
2023
Q4
$450K Sell
1,107
-42
-4% -$17.1K 0.01% 198
2023
Q3
$400K Sell
1,149
-15
-1% -$5.22K 0.01% 188
2023
Q2
$410K Sell
1,164
-1,159
-50% -$408K 0.01% 197
2023
Q1
$732K Buy
2,323
+442
+23% +$139K 0.03% 120
2022
Q4
$543K Sell
1,881
-726
-28% -$210K 0.03% 118
2022
Q3
$755K Sell
2,607
-599
-19% -$173K 0.04% 109
2022
Q2
$903K Sell
3,206
-1,732
-35% -$488K 0.04% 101
2022
Q1
$1.29M Sell
4,938
-13,304
-73% -$3.47M 0.05% 98
2021
Q4
$4.01M Sell
18,242
-555
-3% -$122K 0.14% 73
2021
Q3
$3.41M Sell
18,797
-34,154
-65% -$6.2M 0.13% 77
2021
Q2
$10.7M Buy
52,951
+36,560
+223% +$7.37M 0.37% 53
2021
Q1
$3.52M Sell
16,391
-52,409
-76% -$11.3M 0.14% 79
2020
Q4
$16.3M Buy
68,800
+18,641
+37% +$4.41M 0.8% 38
2020
Q3
$13.6M Buy
+50,159
New +$13.6M 0.77% 36
2019
Q1
Sell
-4,200
Closed -$696K 164
2018
Q4
$696K Buy
+4,200
New +$696K 0.14% 70